Collegium Pharmaceutical, Inc. (NASDAQ: COLL) announced the completion of its acquisition of AZSTARYS from Corium Therapeutics for approximately $650 million ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions